Total Funding
15
Total FundingSeries A raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
CancerGuide Diagnostics is a molecular diagnostics company developing genomic-based clinical and pharmaceutical cancer tests and services.
Myla P. Lai-Goldman: Chief Medical Officer- William B. Haas: President and Chief Operating Officer
About the Company
CancerGuide Diagnostics operates as a molecular diagnostics company. The company engages in the development and commercialization of genomic based clinical and pharmaceutical cancer tests and services. The company was formerly known as Oncogenomics, Inc. CancerGuide Diagnostics, Inc. was founded in 2006 and is based in Durham, North Carolina.
